Cover Image
市場調查報告書

侷限性發作:全球臨床試驗回顧(2011年第1季)

Partial Seizure Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 180505
出版日期 內容資訊 英文 371 Pages
訂單完成後即時交付
價格
Back to Top
侷限性發作:全球臨床試驗回顧(2011年第1季) Partial Seizure Global Clinical Trials Review, H1, 2016
出版日期: 2016年06月30日 內容資訊: 英文 371 Pages
簡介

本報告針對侷限性發作治療藥物提供相關臨床試驗動向、臨床試驗數量與受驗者數量、階段分類、分期狀況、頂尖企業、開發中的治療藥物資料,目錄介紹如下。

介紹

地區分類臨床試驗

  • 國家分類臨床試驗
    • 亞太地區頂尖五國
    • 歐洲頂尖五國
    • 北美頂尖國家
    • 中東・非洲頂尖國家
    • 中南美頂尖國家

BRIC各國臨床試驗

階段分類臨床試驗

分期臨床試驗狀況

未達成的臨床試驗

期限內的受驗者

傑出贊助商

  • 參加臨床試驗的頂尖企業

傑出治療藥物比較

臨床試驗分析

  • 頂尖企業臨床試驗概要
    • UCB S.A.
    • Pfizer Inc
    • Eisai Inc.
    • Bial - Portela & Ca, S.A
    • Johnson & Johnson
    • Novartis AG
    • Lundbeck Inc
    • Supernus Pharmaceuticals, Inc
    • NeuroPace, Inc
    • Cyberonics, Inc
  • 頂尖大學、機關、醫院臨床試驗概要
    • Northeast Regional Epilepsy
    • Le Bonheur Children's Medical Center
    • Abbott Laboratories
    • National Institute of Mental Health (NIMH)
    • The University of Chicago

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3538CTIDB

GlobalData's clinical trial report, "Partial Seizure Global Clinical Trials Review, H1, 2016" provides an overview of Partial Seizure clinical trials scenario. This report provides top line data relating to the clinical trials on Partial Seizure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Partial Seizure to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Partial Seizure to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Partial Seizure Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Partial Seizure
      • May 31, 2016: Zebinix (eslicarbazepine acetate) New Six-year Post-marketing Data Shows Safety Profile is Unchanged as Real-world Study Results are Presented for First Time at the Second Congress of the European Academy of Neurology (EAN) 2016, Copenhagen
      • Apr 15, 2016: Sunovion Announces Results of Health Outcomes Analyses Supporting the Use of Aptiom (eslicarbazepine acetate) in People with Partial-Onset Seizures at the 68th American Academy of Neurology (AAN) Annual Meeting
      • Apr 14, 2016: Once-a-Day Epilepsy Drug May Prevent Seizures as Well as Twice-a-Day Drug
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Partial Seizure Therapeutics, Global, Clinical Trials by Region, 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Partial Seizure Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016*
  • Proportion of Partial Seizure to Central Nervous System Clinical Trials, G7 Countries (%), 2016*
  • Partial Seizure Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Partial Seizure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Partial Seizure to Central Nervous System Clinical Trials, E7 Countries (%), 2016*
  • Partial Seizure Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Partial Seizure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Partial Seizure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Partial Seizure Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Partial Seizure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Partial Seizure Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Partial Seizure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
  • Partial Seizure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016*
  • Proportion of Partial Seizure to Central Nervous System Clinical Trials, G7 Countries (%), 2016*
  • Partial Seizure Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Partial Seizure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Partial Seizure to Central Nervous System Clinical Trials, E7 Countries (%), 2016*
  • Partial Seizure Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Partial Seizure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Partial Seizure Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Partial Seizure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Partial Seizure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top